Our guest today is Frank McGillin, Senior Vice President and General Manager, at NeuroMetrix. He discusses Quell a Class-2 device for Chronic Pain. He lead the start-up of a new consumer health technology business for NeuroMetrix, he developed and executed strategy to enter the rapidly growing wearables segment with Quell, a new Class-2 device for chronic pain.
Mr. McGillin brings to NeuroMetrix over 20 years experience building successful, high-growth consumer brands most recently at Philips Oral Healthcare and at Johnson & Johnson. At Philips Mr. McGillin was responsible for building the global oral care business of Sonicare to become the #1 brand in the nearly $1 billion dollar US power toothbrush market. During his career he has launched over 50 new products and product upgrades and managed businesses across markets including diagnostic imaging, healthcare informatics, medical devices, dental and consumer technology. Mr. McGillin holds an MBA degree from Fordham University and a BS degree from Northeastern University. –
Quell® l is a 100% drug free technology designed for millions of people suffering from chronic pain. The advanced wearable device is lightweight and can be worn during the day while active, and at night while sleeping. It has been cleared by the FDA for treatment of chronic pain without a prescription. In a recent study, 81% of Quell users reported an improvement in their chronic pain. Quell users can personalize and manage therapy discreetly via the Quell Relief app. Quell also offers advanced health tracking relevant to chronic pain sufferers including pain, sleep, activity, and gait. Quell was the winner of the 2016 SXSW (South by Southwest) Innovation Award for Best Wearable Technology. Quell is available at select healthcare professionals and retailers. – For more information about their products go to www.neurometrix.com